5 trials changed in the last 30 days: 0 stopped, 4 with notable changes, 1 with a minor change only.
Primary completion pushed from Sep 30, 2026 to Sep 30, 2028
Also in this update: Study completion pushed from Sep 30, 2028 to Sep 30, 2030
Huashan HospitalNot applicable NCT06623266 Registry history of NCT06623266 on ClinicalTrials.gov (opens the registry)
Updated
Primary completion pushed from Jun 30, 2025 to Dec 31, 2025
Also in this update: Study completion pushed from Dec 1, 2025 to Dec 31, 2026
Huashan HospitalNot specified NCT06617962 Registry history of NCT06617962 on ClinicalTrials.gov (opens the registry)
Updated
Primary endpoint(s) modified
Also in this update: Interventions modified
Huashan HospitalNot applicable NCT06288659 Registry history of NCT06288659 on ClinicalTrials.gov (opens the registry)
Updated
Recruitment opened
Huashan HospitalNot specified NCT06829524 Registry history of NCT06829524 on ClinicalTrials.gov (opens the registry)
Updated
Registry marked status Unknown (sponsor has not verified the record since Sep 2023); last known: Recruiting
Huashan HospitalNot specified NCT04837625 Registry history of NCT04837625 on ClinicalTrials.gov (opens the registry)
Changed
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-09-28 | NCT07844551 ImmunoADC Therapy for Induction Conversion in Patients With Stage IVB OSCC/OPSCC | Phase 2 | Not Yet Recruiting |
| 2026-09-22 | NCT07834450 Efficacy and Safety of Cyclophosphamide in Amyotrophic Lateral Sclerosis | Phase 2 | Not Yet Recruiting |
| Early Phase 1 | 4 | |
| Phase 1 | 1 | |
| Phase 2 | 11 | |
| Phase 2/3 | 2 | |
| Phase 3 | 6 | |
| Phase 4 | 4 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 4 | ||||
| NCT07741292 | Niaoduqing Granules in Older Adults With Impaired Kidney Function | Chronic Kidney Disease | Recruiting | 2026-08-03 |
| NCT06153069 | Asymptomatic TB With Innovative Modified Short-course Regimens | Tuberculosis | Recruiting | 2026-02-11 |
| NCT06966635 | Exploratory Study on the Treatment of Gout With Potassium Citrate Sustained-release… | Hyperuricemia or Gout | Recruiting | 2025-05-13 |
| NCT06900166 | Pegylated Interferon Alfa-2b in Reducing Relapse Rates After Nucleos(t)ide Analogue… | Chronic Hepatitis B | Not Yet Recruiting | 2025-03-28 |
| Phase 3 | ||||
| NCT06329622 | Effect of Ketosteril on Sarcopenia in Patients With Chronic Kidney Disease | Chronic Kidney Disease | Recruiting | 2026-07-28 |
| NCT06022146 | A Novel Therapy With a 1-Month Ultrashort Regimen to Halt Progression From Latent… | Tuberculosis | Recruiting | 2026-07-14 |
| NCT06781944 | OBINOTUZUMAB Versus Cyclophosphamide + Glucocorticoids in Primary Membranous… | Primary Membranous Nephropathy | Recruiting | 2026-01-21 |
| NCT06994975 | CHinese ischEmic Stroke Beyond 4.5 Hours With TeNecteplase Under Optimized Non-Contrast… | Acute Ischemic Stroke | Recruiting | 2025-12-30 |
| NCT05081401 | Innovating(IN) Shorter(S), All- Oral, Precised(P), Individualized(I) Treatment… | Multidrug Resistant Tuberculosis | Recruiting | 2025-04-06 |
| NCT06649721 | Innovating Shorter, All- Oral, Precised Treatment Regimen for Rifampicin Resistant… | Drug-resistant Tuberculosis | Active, Not Recruiting | 2025-09-02 |
| Phase 2/3 | ||||
| NCT07185373 | Orelabrutinib Combined With Teniposide, Rituximab and Methotrexate for Newly Diagnosed… | Primary Central Nervous System Lymphoma | Recruiting | 2026-08-19 |
| NCT05401071 | Optimizing(O) RIfapentine-based(RI) Regimen and shortENing(EN) the Treatment of… | Tuberculosis, Pulmonary | Recruiting | 2023-12-11 |
| Phase 2 | ||||
| NCT07482020 | SGLT2i Improve Left Atrial Function in Patients With Paroxysmal Atrial Fibrillation… | Atrial Fibrillation (AF) | Recruiting | 2026-03-19 |
| NCT07026994 | Colchicine for the Prevention of Recurrence in Cerebral Amyloid Angiopathy RElated… | Cerebral Amyloid Angiopathy | Recruiting | 2025-06-26 |
| NCT06775080 | The Use of Propranolol in the Perioperative Period of Resectable Gastrointestinal Tumors | Gastrointestinal Tumors | Recruiting | 2025-01-14 |
| NCT06054906 | Neoadjuvant of Sintilimab Combined Weekly Metronomic Chemotherapy (PLOF) for Resectable… | Gastric Cancer | Recruiting | 2024-12-30 |
| NCT06091332 | Hemorrhagic Brainstem Cavernous Malformations Treatment With Sirolimus: aSingle Centre… | Cavernous Malformations | Recruiting | 2024-12-20 |
| NCT07844551 | ImmunoADC Therapy for Induction Conversion in Patients With Stage IVB OSCC/OPSCC | Stage IVB Oral Cavity Squamous Cell Carcinoma | Not Yet Recruiting | 2026-09-28 |
| NCT07834450 | Efficacy and Safety of Cyclophosphamide in Amyotrophic Lateral Sclerosis | Amyotrophic Lateral Sclerosis | Not Yet Recruiting | 2026-09-22 |
| NCT07692399 | Safety and Efficacy of Edaravone Dexborneol Sublingual Tablets for Blood-Brain Barrier… | CADASIL | Not Yet Recruiting | 2026-07-09 |
| NCT07634068 | Vertebrobasilar Dolichoectasia Treatment With Amiloride | Vertebrobasilar Dolichoectasia | Not Yet Recruiting | 2026-06-08 |
| NCT07634120 | Vertebrobasilar Dolichoectasia Treatment With Sirolimus | Vertebrobasilar Dolichoectasia | Not Yet Recruiting | 2026-06-08 |
| NCT06780592 | Vebreltinib Combined With Temozolomide for Glioblastoma (GBM) After Surgery | Glioblastoma | Not Yet Recruiting | 2025-01-22 |
| Phase 1 | ||||
| NCT07341828 | A Study of C-CAR168 in the Treatment of Central Nervous System Autoimmune Diseases… | Multiple Sclerosis (MS) | Not Yet Recruiting | 2026-01-15 |
| Early Phase 1 | ||||
| NCT07707531 | A Study to Evaluate the Human Biodistribution and Dosimetry of the Radionuclide Labeled… | Gastric Cancer | Recruiting | 2026-07-16 |
Glioma (7) · Chronic Kidney Disease (5) · Stroke (5) · Gastric Cancer (4) · Head & Neck Cancer (4) · Colorectal Cancer (3) · Glioblastoma (3) · Myasthenia Gravis (3) · Dementia (2) · Hypertension (2)